title: Inflammatory and prothrombotic markers and the progression of renal disease in elderly individuals.
abstract: Inflammatory and prothrombotic markers are elevated in individuals with mild to moderate renal disease. It was hypothesized that these markers may also be determinants of the progression of renal disease. The association of six markers-serum C-reactive protein (CRP), white blood cell (WBC) count, fibrinogen, factor VII, albumin, and hemoglobin-with subsequent elevations of creatinine and decline in estimated GFR in the Cardiovascular Health Study, a community-based cohort of elderly individuals, was analyzed. Linear regression was used to determine predictors of an annualized change in serum creatinine as the main outcome. Duration of follow-up was 7 yr for the original cohort and 4 yr for the more recently recruited black cohort. A total of 588 (12.7%) individuals had a decline in estimated GFR of at least 3 ml/min per yr per 1.73 m(2). Higher CRP (P < 0.001), WBC count (P < 0.001), fibrinogen (P < 0.001), and factor VII (P < 0.001) levels and lower albumin (P < 0.001) and hemoglobin levels (P < 0.001) were associated with a rise in creatinine, after adjusting for age. With additional adjustments for race, gender, baseline creatinine, systolic and diastolic BP, lipid levels, weight, and pack-years smoking, higher CRP, factor VII, fibrinogen, WBC count, and lower albumin and hemoglobin levels remained associated with a rise in creatinine. Similar results were found for decline in estimated GFR. The decline in GFR was greater with increasing number of inflammatory or prothrombotic markers that were above the median (below for hemoglobin and albumin). Inflammatory and prothrombotic markers are predictors for a change in kidney function in elderly individuals. Interventions that reduce inflammation might confer significant cardiovascular and renal benefits.
authors.affiliation: Renal Section, VA Pittsburgh Healthcare System, University Drive C, Mailstop 111F-U, Pittsburgh, PA 15240, USA. Linda.Fried@med.va.gov
authors.forename: Linda
authors.initials: L
authors.lastname: Fried
authors.forename: Cam
authors.initials: C
authors.lastname: Solomon
authors.forename: Michael
authors.initials: M
authors.lastname: Shlipak
authors.forename: Stephen
authors.initials: S
authors.lastname: Seliger
authors.forename: Catherine
authors.initials: C
authors.lastname: Stehman-Breen
authors.forename: Anthony J
authors.initials: AJ
authors.lastname: Bleyer
authors.forename: Paolo
authors.initials: P
authors.lastname: Chaves
authors.forename: Curt
authors.initials: C
authors.lastname: Furberg
authors.forename: Lewis
authors.initials: L
authors.lastname: Kuller
authors.forename: Anne
authors.initials: A
authors.lastname: Newman
mesh_terms: D000368:Aged; D015415:Biomarkers; D002097:C-Reactive Protein / Q000378:metabolism; D003404:Creatinine / Q000097:blood; D005167:Factor VII / Q000378:metabolism; D005260:Female; D005340:Fibrinogen / Q000378:metabolism; D005500:Follow-Up Studies; D005919:Glomerular Filtration Rate; D006454:Hemoglobins; D006801:Humans; D007958:Leukocyte Count; D016014:Linear Models; D008137:Longitudinal Studies; D008297:Male; D011237:Predictive Value of Tests; D011446:Prospective Studies; D051437:Renal Insufficiency / Q000175:diagnosis* / Q000453:epidemiology / Q000276:immunology*; D012709:Serum Albumin; D013927:Thrombosis / Q000175:diagnosis* / Q000453:epidemiology / Q000276:immunology*
chemical_list: D015415:Biomarkers; D006454:Hemoglobins; D012709:Serum Albumin; D005167:Factor VII; D005340:Fibrinogen; D002097:C-Reactive Protein; D003404:Creatinine